K. Paszty et al., EXPRESSION OF HPMCA4B, THE MAJOR FORM OF THE PLASMA-MEMBRANE CALCIUM-PUMP IN MEGAKARYOBLASTOID CELLS IS GREATLY REDUCED IN MATURE HUMAN PLATELETS, Cell calcium, 24(2), 1998, pp. 129-135
Antibodies 5F10 and JA3 (raised against the erythrocyte Ca2+ pump) wer
e used to identify hPMCA4b as the major form of the plasma membrane Ca
2+ pump in human platelets and in three human megakaryoblastoid cell l
ines, MEG 01, DAMI and CHRF 288-11. 5F10 was used because it has been
shown to recognize all known isoforms of the hPMCA and JA3 because it
reacts exclusively with hPMCA4b [Caride A.J., Filoteo A.G., Enyedi A.,
Verma A.K., Penniston J.T. Detection of isoform 4 of the plasma membr
ane calcium pump in human tissues by using isoform-specific monoclonal
antibodies. Biochem J 1996; 316: 353-359]. In addition to hPMCA4b, hP
MCA1b was also detected in the megakaryoblastoid cells by using isofor
m-specific polyclonal antibodies. The apparent size of this isoform, h
owever, was smaller than that seen in HeLa and COS-7 cell membranes in
dicating the presence of a modified form of hPMCA1b. In platelets, no
evidence of the expression of hPMCA1b could be found. The amount of PM
CA in these cells was compared with that of the constitutive form of t
he sarco/endoplasmic reticulum Ca2+ pump in non-muscle cells (SERCA2b)
and also with the amount of PMCA in human erythrocytes. A very low le
vel of the plasma membrane Ca2+ pump was found in platelets while in t
heir precursor cells the expression of this Ca2+ pump was much more ab
undant. Whereas the expression level of PMCA decreased dramatically in
mature human platelets, the expression of SERCA2b did not change subs
tantially upon megakaryocytic differentiation.